To Assess the Safety and Efficacy of the Atrial Shunt Implant System in the Treatment of Patients With Chronic Left Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT05486000
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Registry
-
NCT05486000
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05486000. Allocation not applicable; no masking; primary purpose treatment. Start 2022-08 (anticipated); primary completion 2026-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Assess the Safety and Efficacy of the Atrial Shunt Implant System in the Treatment of Patients With Chronic Left Heart Failure
- Condition
- Left Heart Failure
- Intervention (Device)
- Atrial shunt implant system
- Lead sponsor
- Morningside (Nantong) Medical Co.,Ltd
- Collaborator
- Xiamen Cardiovascular Hospital, Xiamen University
Record details
- Record id
cardio:ct-nct05486000- Content hash
37f327eb15f18da753adb750f470594efb90c434b14f1509478dfa652806dd56